Jobling Rebekah K, Assoum Mirna, Gakh Oleksandr, Blaser Susan, Raiman Julian A, Mignot Cyril, Roze Emmanuel, Dürr Alexandra, Brice Alexis, Lévy Nicolas, Prasad Chitra, Paton Tara, Paterson Andrew D, Roslin Nicole M, Marshall Christian R, Desvignes Jean-Pierre, Roëckel-Trevisiol Nathalie, Scherer Stephen W, Rouleau Guy A, Mégarbané André, Isaya Grazia, Delague Valérie, Yoon Grace
1 Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
2 Inserm, UMR_S 910, 13385, Marseille, France 3 Aix Marseille Université, GMGF, 13385, Marseille, France.
Brain. 2015 Jun;138(Pt 6):1505-17. doi: 10.1093/brain/awv057. Epub 2015 Mar 25.
Non-progressive cerebellar ataxias are a rare group of disorders that comprise approximately 10% of static infantile encephalopathies. We report the identification of mutations in PMPCA in 17 patients from four families affected with cerebellar ataxia, including the large Lebanese family previously described with autosomal recessive cerebellar ataxia and short stature of Norman type and localized to chromosome 9q34 (OMIM #213200). All patients present with non-progressive cerebellar ataxia, and the majority have intellectual disability of variable severity. PMPCA encodes α-MPP, the alpha subunit of mitochondrial processing peptidase, the primary enzyme responsible for the maturation of the vast majority of nuclear-encoded mitochondrial proteins, which is necessary for life at the cellular level. Analysis of lymphoblastoid cells and fibroblasts from patients homozygous for the PMPCA p.Ala377Thr mutation and carriers demonstrate that the mutation impacts both the level of the alpha subunit encoded by PMPCA and the function of mitochondrial processing peptidase. In particular, this mutation impacts the maturation process of frataxin, the protein which is depleted in Friedreich ataxia. This study represents the first time that defects in PMPCA and mitochondrial processing peptidase have been described in association with a disease phenotype in humans.
非进行性小脑共济失调是一组罕见的疾病,约占静止性婴儿脑病的10%。我们报告了在4个患有小脑共济失调的家族的17名患者中鉴定出PMPCA基因的突变,其中包括先前描述的患有常染色体隐性小脑共济失调和诺曼型身材矮小且定位于9号染色体q34区域(OMIM #213200)的黎巴嫩大家族。所有患者均表现为非进行性小脑共济失调,且大多数患者有不同程度的智力障碍。PMPCA编码α-MPP,即线粒体加工肽酶的α亚基,该酶是负责绝大多数核编码线粒体蛋白成熟的主要酶,这在细胞水平上对生命至关重要。对PMPCA p.Ala377Thr突变纯合患者和成纤维细胞系的分析表明,该突变影响PMPCA编码的α亚基水平以及线粒体加工肽酶的功能。特别是,该突变影响了frataxin的成熟过程,而frataxin是弗里德赖希共济失调中缺失的蛋白质。本研究首次描述了PMPCA和线粒体加工肽酶缺陷与人类疾病表型相关。